{"transactions":[{"id":751881,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:46:28.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8519,"price":1.3702,"value":11672.7338,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":321132,"source":{"system":"sec-edgar","filing":"0001780878-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000178087826000003/primarydocument.xml","form_type":"4"}},{"id":858656,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-05T23:47:37.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":13836,"price":1.6599,"value":22966.3764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":329651,"source":{"system":"sec-edgar","filing":"0001780878-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000178087826000002/primarydocument.xml","form_type":"4"}},{"id":877343,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:06:30.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4471,"price":1.7478,"value":7814.4138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":343487,"source":{"system":"sec-edgar","filing":"0001780878-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000178087826000001/primarydocument.xml","form_type":"4"}},{"id":877342,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:06:30.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":13195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of 13,195 performance-based restricted units (\"PRSUs\") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":347958,"source":{"system":"sec-edgar","filing":"0001780878-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000178087826000001/primarydocument.xml","form_type":"4"}},{"id":877341,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:06:30.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":191500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026."}],"balance_after":334763,"source":{"system":"sec-edgar","filing":"0001780878-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000178087826000001/primarydocument.xml","form_type":"4"}},{"id":981654,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-12-03T21:19:31.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9762,"price":2.9002,"value":28311.7524,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":143263,"source":{"system":"sec-edgar","filing":"0001780878-25-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000178087825000002/primarydocument.xml","form_type":"4"}},{"id":1048017,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-09-04T22:33:22.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2854,"price":3.3627,"value":9597.1458,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":153025,"source":{"system":"sec-edgar","filing":"0001562180-25-006100","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025006100/primarydocument.xml","form_type":"4"}},{"id":1125168,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-06-04T01:05:12.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2965,"price":3.6348,"value":10777.182,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":155879,"source":{"system":"sec-edgar","filing":"0001562180-25-004389","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025004389/primarydocument.xml","form_type":"4"}},{"id":1228971,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-03-04T22:21:12.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":7525,"price":4.5771,"value":34442.6775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":158844,"source":{"system":"sec-edgar","filing":"0001562180-25-002005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025002005/primarydocument.xml","form_type":"4"}},{"id":1249745,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:49:32.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":11750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of 11,750 performance-based restricted units (\"PRSUs\") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 200 shares that were previously reported as held by the Reporting Person due to an inadvertent administrative error."}],"balance_after":166369,"source":{"system":"sec-edgar","filing":"0001562180-25-001548","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025001548/primarydocument.xml","form_type":"4"}},{"id":1249744,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:49:32.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments."}],"balance_after":154819,"source":{"system":"sec-edgar","filing":"0001562180-25-001548","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025001548/primarydocument.xml","form_type":"4"}},{"id":1255928,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-02-21T00:58:45.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":6441,"price":5.4266,"value":34952.7306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":85819,"source":{"system":"sec-edgar","filing":"0001562180-25-001452","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025001452/primarydocument.xml","form_type":"4"}},{"id":1300183,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-01-18T01:14:14.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":6442,"price":5.7976,"value":37348.1392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":92260,"source":{"system":"sec-edgar","filing":"0001562180-25-000429","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218025000429/primarydocument.xml","form_type":"4"}},{"id":1326810,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-12-18T22:01:05.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":6442,"price":7.8848,"value":50793.8816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":98702,"source":{"system":"sec-edgar","filing":"0001562180-24-008480","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024008480/primarydocument.xml","form_type":"4"}},{"id":1345187,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:05:19.000Z","date":"2024-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":7766,"price":8.9732,"value":69685.8712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":105144,"source":{"system":"sec-edgar","filing":"0001562180-24-008093","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024008093/primarydocument.xml","form_type":"4"}},{"id":1361856,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-11-18T21:35:40.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":1365,"price":8.5,"value":11602.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":112910,"source":{"system":"sec-edgar","filing":"0001562180-24-007742","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024007742/primarydocument.xml","form_type":"4"}},{"id":1384867,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-10-17T20:09:06.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":1324,"price":8.16,"value":10803.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":114275,"source":{"system":"sec-edgar","filing":"0001562180-24-007368","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024007368/primarydocument.xml","form_type":"4"}},{"id":1403667,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:59:41.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":1324,"price":8.43,"value":11161.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":115599,"source":{"system":"sec-edgar","filing":"0001562180-24-006866","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024006866/primarydocument.xml","form_type":"4"}},{"id":1414032,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:41:58.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1613,"price":7.2691,"value":11725.0583,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":116923,"source":{"system":"sec-edgar","filing":"0001562180-24-006684","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024006684/primarydocument.xml","form_type":"4"}},{"id":1431419,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-08-16T21:01:30.000Z","date":"2024-08-15","kind":"sale","planned":true,"acquired":false,"shares":1328,"price":6.57,"value":8724.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":118536,"source":{"system":"sec-edgar","filing":"0001562180-24-006323","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024006323/primarydocument.xml","form_type":"4"}},{"id":1452651,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-07-17T21:22:55.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":1290,"price":6.51,"value":8397.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":119864,"source":{"system":"sec-edgar","filing":"0001562180-24-005779","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024005779/primarydocument.xml","form_type":"4"}},{"id":1473270,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-06-21T00:35:36.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":1290,"price":6.3725,"value":8220.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":121154,"source":{"system":"sec-edgar","filing":"0001562180-24-005208","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024005208/primarydocument.xml","form_type":"4"}},{"id":1492498,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:15:49.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1716,"price":6.5333,"value":11211.1428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":122444,"source":{"system":"sec-edgar","filing":"0001562180-24-004631","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024004631/primarydocument.xml","form_type":"4"}},{"id":1509057,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-05-20T22:35:00.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":2066,"price":7,"value":14462.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":124160,"source":{"system":"sec-edgar","filing":"0001562180-24-004235","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024004235/primarydocument.xml","form_type":"4"}},{"id":1540041,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-04-17T20:31:17.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":false,"shares":2005,"price":6.11,"value":12250.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":126226,"source":{"system":"sec-edgar","filing":"0001562180-24-003448","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024003448/primarydocument.xml","form_type":"4"}},{"id":1569033,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-03-19T21:04:39.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":2005,"price":7.8043,"value":15647.6215,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":128231,"source":{"system":"sec-edgar","filing":"0001562180-24-002815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024002815/primarydocument.xml","form_type":"4"}},{"id":1596839,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:14:04.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3439,"price":8.0512,"value":27688.0768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":130236,"source":{"system":"sec-edgar","filing":"0001562180-24-002252","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024002252/primarydocument.xml","form_type":"4"}},{"id":1625512,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-02-23T00:34:06.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":3889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of 3,889 performance-based restricted units (\"PRSUs\") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":133675,"source":{"system":"sec-edgar","filing":"0001562180-24-001654","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024001654/primarydocument.xml","form_type":"4"}},{"id":1625511,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-02-23T00:34:06.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments."}],"balance_after":129786,"source":{"system":"sec-edgar","filing":"0001562180-24-001654","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024001654/primarydocument.xml","form_type":"4"}},{"id":1633989,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-02-20T21:10:57.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":3262,"price":9.7654,"value":31854.7348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":64786,"source":{"system":"sec-edgar","filing":"0001562180-24-001434","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024001434/primarydocument.xml","form_type":"4"}},{"id":1676471,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-01-18T22:49:54.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":3163,"price":10.8271,"value":34246.1173,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":68048,"source":{"system":"sec-edgar","filing":"0001562180-24-000542","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218024000542/primarydocument.xml","form_type":"4"}},{"id":1704986,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-12-19T21:07:27.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":3163,"price":8.8279,"value":27922.6477,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":71211,"source":{"system":"sec-edgar","filing":"0001562180-23-008466","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023008466/primarydocument.xml","form_type":"4"}},{"id":1721903,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-12-05T22:38:55.000Z","date":"2023-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4161,"price":7.4503,"value":31000.6983,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":74374,"source":{"system":"sec-edgar","filing":"0001562180-23-008134","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023008134/primarydocument.xml","form_type":"4"}},{"id":1736857,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-11-17T21:20:41.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":1196,"price":8.25,"value":9867.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":78535,"source":{"system":"sec-edgar","filing":"0001562180-23-007757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023007757/primarydocument.xml","form_type":"4"}},{"id":1756971,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-10-20T20:04:40.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":1161,"price":8.33,"value":9671.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":79731,"source":{"system":"sec-edgar","filing":"0001562180-23-007403","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023007403/primarydocument.xml","form_type":"4"}},{"id":1777402,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-09-19T22:09:06.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":1160,"price":11.01,"value":12771.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":80892,"source":{"system":"sec-edgar","filing":"0001562180-23-006963","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023006963/primarydocument.xml","form_type":"4"}},{"id":1787322,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-09-07T00:47:39.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1484,"price":11.7765,"value":17476.326,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":82052,"source":{"system":"sec-edgar","filing":"0001562180-23-006764","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023006764/primarydocument.xml","form_type":"4"}},{"id":1797778,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-08-24T22:29:26.000Z","date":"2023-08-22","kind":"sale","planned":true,"acquired":false,"shares":737,"price":11.9,"value":8770.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1."}],"balance_after":83536,"source":{"system":"sec-edgar","filing":"0001562180-23-006563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023006563/primarydocument.xml","form_type":"4"}},{"id":1867270,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-06-05T23:32:13.000Z","date":"2023-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1548,"price":11.239,"value":17397.972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,510 shares held by the Reporting Person that were not previously reported due to an inadvertent administrative error."}],"balance_after":84273,"source":{"system":"sec-edgar","filing":"0001562180-23-004861","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023004861/primarydocument.xml","form_type":"4"}},{"id":1974093,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:09:16.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":1734,"price":14.2886,"value":24776.4324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":82311,"source":{"system":"sec-edgar","filing":"0001562180-23-002425","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023002425/primarydocument.xml","form_type":"4"}},{"id":1993434,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-02-24T21:10:36.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments."}],"balance_after":84045,"source":{"system":"sec-edgar","filing":"0001562180-23-001831","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023001831/primarydocument.xml","form_type":"4"}},{"id":2007851,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-02-18T00:19:46.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":662,"price":13.82,"value":9148.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":49045,"source":{"system":"sec-edgar","filing":"0001562180-23-001536","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023001536/primarydocument.xml","form_type":"4"}},{"id":2050960,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2023-01-19T22:00:47.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":642,"price":12.12,"value":7781.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":49707,"source":{"system":"sec-edgar","filing":"0001562180-23-000516","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218023000516/primarydocument.xml","form_type":"4"}},{"id":2081802,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-12-20T00:07:41.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":642,"price":11.0031,"value":7063.9902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":50349,"source":{"system":"sec-edgar","filing":"0001562180-22-008374","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022008374/primarydocument.xml","form_type":"4"}},{"id":2096293,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-12-05T21:38:12.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":3557,"price":10.6497,"value":37880.9829,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":50991,"source":{"system":"sec-edgar","filing":"0001562180-22-008048","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022008048/primarydocument.xml","form_type":"4"}},{"id":2112306,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-11-17T21:12:01.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":669,"price":10.8155,"value":7235.5695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":54548,"source":{"system":"sec-edgar","filing":"0001562180-22-007729","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022007729/primarydocument.xml","form_type":"4"}},{"id":2134187,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-10-20T21:20:08.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":648,"price":9.53,"value":6175.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":55217,"source":{"system":"sec-edgar","filing":"0001562180-22-007297","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022007297/primarydocument.xml","form_type":"4"}},{"id":2155834,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-09-19T21:07:57.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":648,"price":10.99,"value":7121.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":55865,"source":{"system":"sec-edgar","filing":"0001562180-22-006734","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022006734/primarydocument.xml","form_type":"4"}},{"id":2165779,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-09-06T20:11:16.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":848,"price":11.605,"value":9841.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":56513,"source":{"system":"sec-edgar","filing":"0001562180-22-006495","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022006495/primarydocument.xml","form_type":"4"}},{"id":2184370,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-08-16T20:51:12.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":668,"price":13.14,"value":8777.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":57361,"source":{"system":"sec-edgar","filing":"0001562180-22-006117","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022006117/primarydocument.xml","form_type":"4"}},{"id":2204585,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-07-20T20:05:51.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":648,"price":16.06,"value":10406.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":58029,"source":{"system":"sec-edgar","filing":"0001562180-22-005729","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022005729/primarydocument.xml","form_type":"4"}},{"id":2230061,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-06-16T20:58:17.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":648,"price":12.2,"value":7905.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":58677,"source":{"system":"sec-edgar","filing":"0001562180-22-005151","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022005151/primarydocument.xml","form_type":"4"}},{"id":2244962,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-06-03T21:46:54.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":30,"price":14.9522,"value":448.566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3)."}],"balance_after":59325,"source":{"system":"sec-edgar","filing":"0001562180-22-004818","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022004818/primarydocument.xml","form_type":"4"}},{"id":2244961,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-06-03T21:46:54.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":818,"price":14.2371,"value":11645.9478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive."}],"balance_after":59355,"source":{"system":"sec-edgar","filing":"0001562180-22-004818","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022004818/primarydocument.xml","form_type":"4"}},{"id":2265842,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-05-18T23:47:04.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":1860,"price":15.87,"value":29518.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":60173,"source":{"system":"sec-edgar","filing":"0001562180-22-004222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022004222/primarydocument.xml","form_type":"4"}},{"id":2292795,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-04-21T23:10:48.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":200,"price":23.21,"value":4642.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":62033,"source":{"system":"sec-edgar","filing":"0001562180-22-003506","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022003506/primarydocument.xml","form_type":"4"}},{"id":2292794,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-04-21T23:10:48.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":1839,"price":22.5165,"value":41407.8435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $22.14 to $22.92 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":62233,"source":{"system":"sec-edgar","filing":"0001562180-22-003506","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022003506/primarydocument.xml","form_type":"4"}},{"id":2327801,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-17T21:42:46.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":2039,"price":21.081,"value":42984.159,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":64072,"source":{"system":"sec-edgar","filing":"0001562180-22-002751","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022002751/primarydocument.xml","form_type":"4"}},{"id":2348103,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-07T23:21:24.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":218,"price":26.8882,"value":5861.6276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1."}],"balance_after":66111,"source":{"system":"sec-edgar","filing":"0001562180-22-002417","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022002417/primarydocument.xml","form_type":"4"}},{"id":2354979,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-04T00:36:22.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":198,"price":26.6913,"value":5284.8774,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (4)."}],"balance_after":66329,"source":{"system":"sec-edgar","filing":"0001562180-22-002344","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022002344/primarydocument.xml","form_type":"4"}},{"id":2354978,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-04T00:36:22.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":1861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of 1,861 performance-based restricted units (\"PRSUs\") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022."}],"balance_after":66527,"source":{"system":"sec-edgar","filing":"0001562180-22-002344","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022002344/primarydocument.xml","form_type":"4"}},{"id":2354977,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-04T00:36:22.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":1216,"price":26.6307,"value":32382.9312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive."}],"balance_after":64666,"source":{"system":"sec-edgar","filing":"0001562180-22-002344","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022002344/primarydocument.xml","form_type":"4"}},{"id":2369192,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-01T02:24:20.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2022 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments."}],"balance_after":65882,"source":{"system":"sec-edgar","filing":"0001562180-22-002021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022002021/primarydocument.xml","form_type":"4"}},{"id":2414206,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T22:30:54.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":5820,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-22-001075","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022001075/primarydocument.xml","form_type":"4"}},{"id":2414205,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-02-03T22:30:54.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":1100,"price":30,"value":33000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."}],"balance_after":30882,"source":{"system":"sec-edgar","filing":"0001562180-22-001075","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022001075/primarydocument.xml","form_type":"4"}},{"id":2414204,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-02-03T22:30:54.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":1100,"price":10.8,"value":11880.0,"ownership":{"direct":true},"balance_after":31982,"source":{"system":"sec-edgar","filing":"0001562180-22-001075","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022001075/primarydocument.xml","form_type":"4"}},{"id":2441714,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-07T02:07:56.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":6920,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":950},"source":{"system":"sec-edgar","filing":"0001562180-22-000329","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022000329/primarydocument.xml","form_type":"4"}},{"id":2441713,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-07T02:07:56.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022."}],"balance_after":4754,"derivative":{"exercise_price":11.78,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-22-000329","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022000329/primarydocument.xml","form_type":"4"}},{"id":2441712,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-01-07T02:07:56.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":3234,"price":40.23,"value":130103.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."}],"balance_after":30882,"source":{"system":"sec-edgar","filing":"0001562180-22-000329","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022000329/primarydocument.xml","form_type":"4"}},{"id":2441711,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-01-07T02:07:56.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":1100,"price":11.78,"value":12958.0,"ownership":{"direct":true},"balance_after":34116,"source":{"system":"sec-edgar","filing":"0001562180-22-000329","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022000329/primarydocument.xml","form_type":"4"}},{"id":2441710,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-01-07T02:07:56.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":2050,"price":10.8,"value":22140.0,"ownership":{"direct":true},"balance_after":33016,"source":{"system":"sec-edgar","filing":"0001562180-22-000329","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218022000329/primarydocument.xml","form_type":"4"}},{"id":2482387,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":23498,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482386,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022."}],"balance_after":5854,"derivative":{"exercise_price":11.78,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482385,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":743,"price":37.6135,"value":27946.8305,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold ranging from $37.45 to $38.17 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in Footnotes (4) - (7)."}],"balance_after":30966,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482384,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":1100,"price":42.87,"value":47157.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."}],"balance_after":31709,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482383,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":200,"price":41.56,"value":8312.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $41.53 to $41.59 per share, inclusive."}],"balance_after":32809,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482382,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":500,"price":40.304,"value":20152.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $40.05 to $40.62 per share, inclusive."}],"balance_after":33009,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482381,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":400,"price":39.2025,"value":15681.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $38.90 to $39.74 per share, inclusive."}],"balance_after":33509,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482380,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":1100,"price":10.8,"value":11880.0,"ownership":{"direct":true},"balance_after":33909,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482379,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":1100,"price":11.78,"value":12958.0,"ownership":{"direct":true},"balance_after":32809,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2482378,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:14:11.000Z","date":"2021-12-02","kind":"tax_withholding","acquired":false,"shares":2839,"price":41.9475,"value":119088.9525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade."}],"balance_after":31709,"source":{"system":"sec-edgar","filing":"0001562180-21-007533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021007533/primarydocument.xml","form_type":"4"}},{"id":2529067,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-02T20:30:12.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":24598,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001562180-21-006757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006757/primarydocument.xml","form_type":"4"}},{"id":2529066,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-02T20:30:12.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022."}],"balance_after":6954,"derivative":{"exercise_price":11.78,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-006757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006757/primarydocument.xml","form_type":"4"}},{"id":2529065,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-11-02T20:30:12.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":600,"price":54.0817,"value":32449.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $54.06 to $54.15 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in Footnotes (2) and (3)."}],"balance_after":34548,"source":{"system":"sec-edgar","filing":"0001562180-21-006757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006757/primarydocument.xml","form_type":"4"}},{"id":2529064,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-11-02T20:30:12.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":2700,"price":53.4874,"value":144415.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $53.05 to $54.03 per share, inclusive."}],"balance_after":35148,"source":{"system":"sec-edgar","filing":"0001562180-21-006757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006757/primarydocument.xml","form_type":"4"}},{"id":2529063,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-11-02T20:30:12.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":1100,"price":11.78,"value":12958.0,"ownership":{"direct":true},"balance_after":37848,"source":{"system":"sec-edgar","filing":"0001562180-21-006757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006757/primarydocument.xml","form_type":"4"}},{"id":2529062,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-11-02T20:30:12.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":2200,"price":10.8,"value":23760.0,"ownership":{"direct":true},"balance_after":36748,"source":{"system":"sec-edgar","filing":"0001562180-21-006757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006757/primarydocument.xml","form_type":"4"}},{"id":2549264,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T00:01:02.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":26798,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":950},"source":{"system":"sec-edgar","filing":"0001562180-21-006325","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006325/primarydocument.xml","form_type":"4"}},{"id":2549263,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T00:01:02.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022."}],"balance_after":8054,"derivative":{"exercise_price":11.78,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001562180-21-006325","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006325/primarydocument.xml","form_type":"4"}},{"id":2549262,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-10-06T00:01:02.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":2200,"price":49.2009,"value":108241.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $48.76 to $49.69 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote."}],"balance_after":34548,"source":{"system":"sec-edgar","filing":"0001562180-21-006325","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006325/primarydocument.xml","form_type":"4"}},{"id":2549261,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-10-06T00:01:02.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1059,"price":50.01,"value":52960.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."}],"balance_after":36748,"source":{"system":"sec-edgar","filing":"0001562180-21-006325","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006325/primarydocument.xml","form_type":"4"}},{"id":2549260,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-10-06T00:01:02.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":950,"price":10.8,"value":10260.0,"ownership":{"direct":true},"balance_after":37807,"source":{"system":"sec-edgar","filing":"0001562180-21-006325","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006325/primarydocument.xml","form_type":"4"}},{"id":2549259,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-10-06T00:01:02.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":2200,"price":11.78,"value":25916.0,"ownership":{"direct":true},"balance_after":36857,"source":{"system":"sec-edgar","filing":"0001562180-21-006325","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021006325/primarydocument.xml","form_type":"4"}},{"id":2575976,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-08T20:08:16.000Z","date":"2021-09-03","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":27748,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-005871","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005871/primarydocument.xml","form_type":"4"}},{"id":2575975,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-08T20:08:16.000Z","date":"2021-09-03","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022."}],"balance_after":10254,"derivative":{"exercise_price":11.78,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-005871","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005871/primarydocument.xml","form_type":"4"}},{"id":2575974,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-08T20:08:16.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":3179,"price":54.2693,"value":172522.1047,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $53.86 to $54.66 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote."}],"balance_after":34657,"source":{"system":"sec-edgar","filing":"0001562180-21-005871","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005871/primarydocument.xml","form_type":"4"}},{"id":2575973,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-08T20:08:16.000Z","date":"2021-09-03","kind":"exercise","acquired":true,"shares":1100,"price":10.8,"value":11880.0,"ownership":{"direct":true},"balance_after":37836,"source":{"system":"sec-edgar","filing":"0001562180-21-005871","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005871/primarydocument.xml","form_type":"4"}},{"id":2575972,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-08T20:08:16.000Z","date":"2021-09-03","kind":"exercise","acquired":true,"shares":1100,"price":11.78,"value":12958.0,"ownership":{"direct":true},"balance_after":36736,"source":{"system":"sec-edgar","filing":"0001562180-21-005871","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005871/primarydocument.xml","form_type":"4"}},{"id":2579511,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:06:47.000Z","date":"2021-09-01","kind":"tax_withholding","acquired":false,"shares":475,"price":54.2321,"value":25760.2475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.91 to $54.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":35636,"source":{"system":"sec-edgar","filing":"0001562180-21-005801","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005801/primarydocument.xml","form_type":"4"}},{"id":2615103,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":41767,"kind":"person","name":"Llewelyn Linda","position":1,"cik":"0001780878","reported_name":"Llewelyn Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T20:29:20.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":28848,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-005166","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780878/000156218021005166/primarydocument.xml","form_type":"4"}}],"next_cursor":"2021-08-04T20:29:20.000000Z,2615103"}